Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P3.13 - Targeted Therapy (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 35
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.13-01 - Detecting ALK Rearrangements in NSCLC Patients: IHC, FISH or NGS Fusion?
12:00 - 13:30 | Presenter: Alfredo Addeo
- Abstract
Loading... -
+
P3.13-02 - Lymphocytic Plevral Effusion Due to Crizotinib Usage: First Case in Literature
12:00 - 13:30 | Presenter: Pınar Akın Kabalak
- Abstract
Loading... -
+
P3.13-03 - Real-World Anaplastic Lymphoma Kinase Testing Practices: Results from a Survey in the United States
12:00 - 13:30 | Author(s): Ken Bloom
- Abstract
Loading... -
+
P3.13-04 - Lorlatinib in Anaplastic Lymphoma Kinase and Proto-Oncogene Tyrosine-Protein Kinase ROS-Positive Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Marthe Sentijna Paats
- Abstract
Loading... -
+
P3.13-05 - Use of Crizotinib in a Patient with a Ros Mutation Causing Elevated CPK and Resulting in Dose Limiting: Case Report
12:00 - 13:30 | Author(s): Bárbara Maria Lafayette Viana da Luz
- Abstract
Loading... -
+
P3.13-06 - Analysis of ALK Rearrangement Non-Small Cell Lung Cancer Cell Blocks from Pleural Effusion
12:00 - 13:30 | Presenter: Chunwei Xu
- Abstract
Loading... -
+
P3.13-07 - The Effect of Crizotinib in Patients of Non Small Cell Lung Cancer with Brain Metastases: A Retrospective Analysis
12:00 - 13:30 | Presenter: Jiexia Zhang
- Abstract
Loading... -
+
P3.13-08 - Assessment of EGFR Gene Mutations In cf-DNA in Monitoring of Response to EGFR TKIs in Patients with Lung Adenocarcinoma
12:00 - 13:30 | Author(s): Marcin Nicoś
- Abstract
Loading... -
+
P3.13-09 - ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line
12:00 - 13:30 | Presenter: Baohui Han
- Abstract
Loading... -
+
P3.13-10 - Factors Associated with Long-Term Survival of Stage IV NSCLC Patients on First-Line EGFR-Targeting Therapy
12:00 - 13:30 | Presenter: Amanda Jane Williams Gibson
- Abstract
Loading... -
+
P3.13-11 - Advanced Nsclc Treated with Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study
12:00 - 13:30 | Presenter: Peter Berzinec
- Abstract
Loading... -
+
P3.13-12 - A Lung Adenocarcinoma with Concomitant EGFR and de novo MET Amplification Response Well to Combination of TKI and Bevacizumab
12:00 - 13:30 | Presenter: Qian Chu
- Abstract
Loading... -
+
P3.13-13 - Afatinib in Lung Adenocarcinoma Harboring de novo EGFR Exon 20 Insertions.
12:00 - 13:30 | Presenter: Marcos André Costa
- Abstract
Loading... -
+
P3.13-14 - Identification of Novel Mutations by High-Throughout Sequencing in T790M Wildtype/cMET Unamplified NSCLC with Acquired Resistance to EGFR TKIs
12:00 - 13:30 | Presenter: Chenguang Li
- Abstract
Loading... -
+
P3.13-15 - First-Line Afatinib Dose Initiation and Adjustment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Chong-Kin Liam
- Abstract
Loading... -
+
P3.13-16 - Concomitant EML4-ALK Rearrangement and EGFR Mutation in Non-Small Cell Lung Cancer Patients: Data from Eastern Indian Hospital.
12:00 - 13:30 | Presenter: Prasanta Raghab Mohapatra
- Abstract
Loading... -
+
P3.13-17 - A Retrospective Study: Central Nervous System Response to Osimertinib in Patients with Advanced NSCLC
12:00 - 13:30 | Presenter: Yuxin Mu
- Abstract
Loading... -
+
P3.13-18 - Mechanisms of Acquired Resistance to Afatinib Clarified with Liquid Biopsy
12:00 - 13:30 | Presenter: Tomomi Nakamura
- Abstract
Loading... -
+
P3.13-19 - Surgery for cIIIB Lung Adenocarcinoma After Response to Erlotinib, Survival and Management of Postoperative Oligoprogressions
12:00 - 13:30 | Presenter: Danail Borisov Petrov
- Abstract
Loading... -
+
P3.13-20 - Frequency of EGFR Mutations in Patients with Adenocarcinoma Lung Cancer. Comparative Study Between Public and Private Mexican Health Services
12:00 - 13:30 | Author(s): Guillermo Martos Ramírez
- Abstract
Loading... -
+
P3.13-21 - Apatinib Plus Icotinib as First-Line Therapy For EGFR Co-Mutations NSCLC in Chinese Patients: An Exploratory Study
12:00 - 13:30 | Presenter: Yanhong Shang
- Abstract
Loading... -
+
P3.13-22 - Real World Study of Afatinib in First-Line or Re-Challenge Setting for Patients with EGFR Mutant Non-Small Cell Lung Cancer.
12:00 - 13:30 | Presenter: Hisashi Tanaka
- Abstract
Loading... -
+
P3.13-23 - EGFR-TKIs Combined Hydroxycamptothecin Improved Outcomes in EGFR-Mutant NSCLC Patients Who Harboring Pericardial Effusion.
12:00 - 13:30 | Author(s): Xiaomeng Wang
- Abstract
Loading... -
+
P3.13-24 - Efficacy of EGFR-TKIs Compared with Chemotherapy as First-Line Therapy in Patients with EGFR Rare Mutation Advanced Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Huijuan Wang
- Abstract
Loading... -
+
P3.13-25 - Development of a Comprehensive Genomic Profiling System to Detect Actionable Genetic Alterations and Tumor Mutation Burden
12:00 - 13:30 | Author(s): Sian Jones
- Abstract
Loading... -
+
P3.13-26 - Outcomes of Patients with Metastatic Lung Cancer Presented in a Multidisciplinary Molecular Tumor Board
12:00 - 13:30 | Presenter: Lisa Pei Chu
- Abstract
Loading... -
+
P3.13-27 - Clinical Outcomes of Patients with Lung Adenocarcinoma Harboring Concomitant Driver Mutations in a Brazilian Cancer Center
12:00 - 13:30 | Presenter: Marcos André Costa
- Abstract
Loading... -
+
P3.13-28 - Heterogeneity, Prevalence and Prognostic Significance of PDL1 Expression in Early Resected NSCLC
12:00 - 13:30 | Presenter: Michelle Dean
- Abstract
Loading... -
+
P3.13-29 - Patient-Derived Xenograft Models(PDX) of Lung Squamous Cell Carcinoma(SCC) for Preclinical Studies
12:00 - 13:30 | Presenter: Tae Ho Kim
- Abstract
Loading... -
+
P3.13-30 - Driver Mutation in Heavy Smoker Patient with Squamous Cell Carcinoma Metastatic Lung Cancer: Case Report
12:00 - 13:30 | Presenter: Bárbara Maria Lafayette Viana da Luz
- Abstract
Loading... -
+
P3.13-31 - Creating a Precision Medicine Pipeline for Lung Cancers.
12:00 - 13:30 | Presenter: Paola A Marignani
- Abstract
Loading... -
+
P3.13-32 - Drug Sensitivity of Lung Adenocarcinoma Towards Inducers of Epigenetic Modifications
12:00 - 13:30 | Presenter: Isabelle Moneke
- Abstract
Loading... -
+
P3.13-33 - Lung Adenocarcinoma Harboring RET Fusion and Dramatic Response to Combination of Vandetanib (VAN) and Everolimus (EVE): A Case Report from Brazil
12:00 - 13:30 | Author(s): Isabella Drumond Figueiredo
- Abstract
Loading... -
+
P3.13-34 - RET Gene, a New Choice for NSCLC
12:00 - 13:30 | Author(s): Yucong Wang
- Abstract
Loading... -
+
P3.13-35 - Antitumor Effect of Neratinib Targeting HER2-Altered Lung Cancer
12:00 - 13:30 | Presenter: Yusuke Ogoshi
- Abstract
Loading...
-
+
P3.15 - Treatment in the Real World - Support, Survivorship, Systems Research (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 30
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.15-01 - Long-Term Outcomes of Pulmonary Metastasectomy: A 12-Year Dual Centre Experience
12:00 - 13:30 | Author(s): Nima Yaftian
- Abstract
Loading... -
+
P3.15-02 - Carboplatin Dose Calculated Using Different Formula for eGFR and Their Comparison with Actual Dose Administered in Lung Cancer Patients
12:00 - 13:30 | Presenter: Digambar Behera
- Abstract
Loading... -
+
P3.15-03 - Capturing the Patient Experience for the Treatment of EGFR Exon 20 Mutations in Non-Small Cell Lung Cancer
12:00 - 13:30 | Author(s): Jill Bell
- Abstract
Loading... -
+
P3.15-04 - An Interdisciplinary Educational Program Dedicated to Non-Small Cell Lung Cancer Patients to Improve their Quality of Life
12:00 - 13:30 | Presenter: Laurence Bigay-Gamé
- Abstract
Loading... -
+
P3.15-05 - Patient Reported Outcomes (PROs) as Performance Measures After Surgery for Lung Cancer
12:00 - 13:30 | Presenter: Majken Munk Brønserud
- Abstract
Loading... -
+
P3.15-06 - Capillary Leak Syndrome in a Primary Lung Adenocarcinoma Patient with Thrombocytopenia from Interleukin-11 Treatment
12:00 - 13:30 | Presenter: Huafei Chen
- Abstract
Loading... -
+
P3.15-07 - A Literature Review and Assessment of Lung Cancer Quality Indicators
12:00 - 13:30 | Presenter: Kim-Lin Chiew
- Abstract
Loading... -
+
P3.15-08 - Patient-Reported Outcomes (PROs) in Patients with Lung Resection: Open Versus Minimal Invasive Surgery
12:00 - 13:30 | Author(s): Wei Dai
- Abstract
Loading... -
+
P3.15-09 - Are Lung Cancer Patients Receiving Education Materials? The Healthcare Provider Perspective on Distribution Gaps and Possible Solutions
12:00 - 13:30 | Author(s): Upal Basu Roy
- Abstract
Loading... -
+
P3.15-10 - Survival Impact of Peripheral Blood Ratios in Lung Cancer According Clinical Stage
12:00 - 13:30 | Presenter: Claudio Flores
- Abstract
Loading... -
+
P3.15-11 - Association Between Peripheral Blood Ratios and Clinical Stage Disease in Lung Cancer.
12:00 - 13:30 | Presenter: Claudio Flores
- Abstract
Loading... -
+
P3.15-12 - Survival Impact of Patient Enrollment in Antineoplastic Drug Trials for Stage IV Non-Small Cell Lung Cancer (NSCLC)
12:00 - 13:30 | Presenter: Bernardo H.L. Goulart
- Abstract
Loading... -
+
P3.15-13 - Surgical Management of Huge Pulmonary Arteriovenous Malformations: Our Experience
12:00 - 13:30 | Presenter: Fadil Gradica
- Abstract
Loading... -
+
P3.15-14 - Using Creative Co-Production to Develop a Treatment Decision Support Tool for People with Malignant Pleural Effusion
12:00 - 13:30 | Author(s): Cheryl Grindell
- Abstract
Loading... -
+
P3.15-15 - ALI Could Be a One of Prognostic Survival Factor for Non-Small Cell Lung Cancer Patients
12:00 - 13:30 | Presenter: Yoichiro Hamamoto
- Abstract
Loading... -
+
P3.15-16 - Management of Patients with ALK-Translocated NSCLC: A Simulation-Based Assessment of Medical Oncologists’ Practice Decisions
12:00 - 13:30 | Author(s): Tara Herrmann
- Abstract
Loading... -
+
P3.15-17 - Lung Cancer Symptom Burden and Quality of Life: Findings from the Cancer Experience Registry
12:00 - 13:30 | Author(s): Alexandra Katherine Zaleta
- Abstract
Loading... -
+
P3.15-18 - Comparison of Pain Control Effects and Side Effects Early After VATs Lobectomy Between IV-PCA, Epidural-PCA and On-Q
12:00 - 13:30 | Presenter: Joonho Jung
- Abstract
Loading... -
+
P3.15-19 - Risk Factors for Osteoporosis in Lung Cancer Patients
12:00 - 13:30 | Author(s): Juwhan Choi
- Abstract
Loading... -
+
P3.15-20 - Palliative Sedation in Lung Cancer Patients Whom Needs Immediate or Elective Intractable Symptom Control
12:00 - 13:30 | Presenter: Fatih Kose
- Abstract
Loading... -
+
P3.15-21 - Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Chong-Kin Liam
- Abstract
Loading... -
+
P3.15-22 - Validation of Eurolung Risk Models in a Japanese Population: A Retrospective Single-Center Analysis of 612 Cases
12:00 - 13:30 | Presenter: Akihiro Nagoya
- Abstract
Loading... -
+
P3.15-23 - Data Mining the Internet and Crowdsourcing in Guiding Patient Decision-Making.
12:00 - 13:30 | Presenter: Shaneel Pathak
- Abstract
Loading... -
+
P3.15-24 - Ramathibodi Lung Cancer Consortium (RLC) Model: Multidisciplinary Team Approach Improves Lung Cancer Patients’ Survival Outcome
12:00 - 13:30 | Presenter: Thanyanan Reungwetwattana
- Abstract
Loading... -
+
P3.15-26 - Safety of Nivolumab in Thoracic Malignancies: Results from a Single Institution in Bangladesh
12:00 - 13:30 | Presenter: Md Shuayb
- Abstract
Loading... -
+
P3.15-27 - Initial Response to First Line Treatment is the Best Predictor of the Patient Survival in Advanced NSCLC
12:00 - 13:30 | Presenter: Nazim Serdar Turhal
- Abstract
Loading... -
+
P3.15-28 - Prognostic Nutritional Index for Predicting Postoperative Complications After Surgery Thoracic Tumor Involving the Neighboring Structures
12:00 - 13:30 | Presenter: Isamu Watanabe
- Abstract
Loading... -
+
P3.15-29 - Defining the Symptom Burden of Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Meagan Whisenant
- Abstract
Loading... -
+
P3.15-30 - Treatment Patterns and Survival of Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Era of Novel Therapies
12:00 - 13:30 | Presenter: Dimas Yusuf
- Abstract
Loading... -
+
P3.15-31 - Better Clinical Outcomes and Resistance Mechanisms of Crizotinib in ALK-Positive Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Yongchang Zhang
- Abstract
Loading...
-
+
P3.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 47
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.16-01 - A Multi-Omic Study Reveals BTG2 as a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: David C Christiani
- Abstract
Loading... -
+
P3.16-02 - Phase III Study of Canakinumab (ACZ885) as Adjuvant Therapy in Patients with Surgically Resected NSCLC
12:00 - 13:30 | Presenter: Edward B Garon
- Abstract
Loading... -
+
P3.16-03 - Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Kazuki Hayasaka
- Abstract
Loading... -
+
P3.16-04 - Comparison of 2D and 3D Consolidation to Tumor Ratios to Predict Less Invasive Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Toshihiro Ikeda
- Abstract
Loading... -
+
P3.16-05 - A Nanotechnology-Enabled Strategy for Image-Guided Transbronchial and Transpleural Photothermal Therapy of Peripheral Lung Cancer
12:00 - 13:30 | Presenter: Tomonari Kinoshita
- Abstract
Loading... -
+
P3.16-06 - Does Comprehensive Mutation Analysis Add Prognostic Value in Resected Early Stage Lung Adenocarcinoma?
12:00 - 13:30 | Presenter: Peter J. Kneuertz
- Abstract
Loading... -
+
P3.16-07 - The Impact of Clinical and Molecular Profile of Resected EGFR-Mutant Non-Small Cell Lung Cancer on the Risk of Developing Brain Metastases
12:00 - 13:30 | Presenter: Mor Moskovitz
- Abstract
Loading... -
+
P3.16-08 - Baseline Quality of Life is Influenced by the Duration of Abstinence from Smoking in Candidates to Lung Cancer Surgery
12:00 - 13:30 | Presenter: Cecilia Pompili
- Abstract
Loading... -
+
P3.16-09 - High Preoperative D-Dimer Level Predicts Early Recurrence After Surgery for Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Yuki Shiina
- Abstract
Loading... -
+
P3.16-10 - Radiomic Features on CT are Prognostic of Recurrence as well as Predictive of Added Benefit of Adjuvant Chemotherapy in ES-NSCLC
12:00 - 13:30 | Presenter: Pranjal Vaidya
- Abstract
Loading... -
+
P3.16-11 - Pattern of Recurrence of Completely Resected Lung Adenocarcinoma Varies According to EGFR Mutation Status
12:00 - 13:30 | Presenter: Katsuya Watanabe
- Abstract
Loading... -
+
P3.16-12 - Standard Conventional Lobectomy vs Stereotactic Body Radiotherapy in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC) – A Review
12:00 - 13:30 | Presenter: Prakash Balakrishnan
- Abstract
Loading... -
+
P3.16-14 - SBRT in Early Stages of Lung Cancer
12:00 - 13:30 | Presenter: Luis Fernández Fornos
- Abstract
Loading... -
+
P3.16-15 - Kinetic Energy Distribution for Gated Technique at Lung Ablative Body Radiotherapy (SABR)
12:00 - 13:30 | Presenter: Kaile Li
- Abstract
Loading... -
+
P3.16-16 - Long Term Outcomes of Body Gamma-Ray Stereotactic Ablative Radiotherapy for Patients with Stage I/II Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Hongqi Li
- Abstract
Loading... -
+
P3.16-17 - Cardiac Sparing in Stereotactic Body Radiotherapy of Early Stage NSCLC Patients
12:00 - 13:30 | Presenter: Barbara Stam
- Abstract
Loading... -
+
P3.16-18 - Modern Radiotherapy Increases Patient Access to Curative Intent Radiotherapy in Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Karen Tumelty
- Abstract
Loading... -
+
P3.16-19 - Clinical Outcomes of Stereotactic Body Radiation Therapy for T2N0M0 Non-Small Cell Lung Cancer
12:00 - 13:30 | Author(s): Yaoyao Zhu
- Abstract
Loading... -
+
P3.16-20 - Feasibility of Limited Resection for Peripheral Small-Sized Non-Small Cell Lung Cancer According to FDG Accumulation and Imaging Findings
12:00 - 13:30 | Presenter: Masato Aragaki
- Abstract
Loading... -
+
P3.16-21 - Robotic Thoracic Surgery in Lung Cancer Resection – A Comprehensive Review
12:00 - 13:30 | Presenter: Prakash Balakrishnan
- Abstract
Loading... -
+
P3.16-22 - Wedge Resection for Small Pulmonary Lesions with Preoperative Bronchoscopic Barium Marking
12:00 - 13:30 | Presenter: Tatsuo Furuya
- Abstract
Loading... -
+
P3.16-23 - Soft-Tissue Sarcoma of the Chest Wall, Surgical Resection: Analysis Our Cases Period of Time Decembre 2004-July 2017
12:00 - 13:30 | Presenter: Fadil Gradica
- Abstract
Loading... -
+
P3.16-24 - Prognostic Value of Positive Lymph Node Ratio in Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Jiaxi He
- Abstract
Loading... -
+
P3.16-25 - Impact of Diabetes Mellitus on Survival Outcome in Patients with Pathological Stage IA Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Shunki Hirayama
- Abstract
Loading... -
+
P3.16-26 - Anatomic Segmentectomy in Stage I Non-Small-Cell Lung Cancer Reveals Equivalent Long-Term Outcomes Compared to Lobectomy
12:00 - 13:30 | Presenter: Alireza Hoda
- Abstract
Loading... -
+
P3.16-27 - Clinical Outcome of Preoperative Intervention Bronchoscopy Followed by Surgery
12:00 - 13:30 | Presenter: Yasufumi Kato
- Abstract
Loading... -
+
P3.16-28 - Surgery of Stage I Non-Small Cell Lung Cancer in Patients Aged 70 Years or Older
12:00 - 13:30 | Presenter: Osamu Kawamata
- Abstract
Loading... -
+
P3.16-29 - Prediction of Lymph Node Metastases in Clinical T1aN0M0 Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Tung-Ming Tsai
- Abstract
Loading... -
+
P3.16-30 - The Impact of the Surgical Approach on Lymph Node Upstaging in Curative Intent Lung Cancer Surgery
12:00 - 13:30 | Presenter: Khaled Mardanzai
- Abstract
Loading... -
+
P3.16-31 - Younger Patients Operated for Lung Cancer Have Better Overall Survival
12:00 - 13:30 | Presenter: Tomasz Marjanski
- Abstract
Loading... -
+
P3.16-32 - A Study of Postoperative Recurrence in Pathological Stage 1 Non-Small Cell Lung Cancer Patients
12:00 - 13:30 | Presenter: Kotaro Mizuno
- Abstract
Loading... -
+
P3.16-33 - Characteristics and Risk Factors of Recurrence After Segmentectomy in Patients With Clinical Stage I Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Akihiro Nakamura
- Abstract
Loading... -
+
P3.16-34 - The Impact of Preoperative Exercise Therapy on the Surgical Outcomes of Patients with Lung Cancer and COPD: A Systematic Review and Meta-Analysis
12:00 - 13:30 | Presenter: Wu Nan
- Abstract
Loading... -
+
P3.16-35 - Stair Climbing Exercise May Ameliorate Pulmonary Function Impairment in Patients at One Month After Lung Cancer Resection
12:00 - 13:30 | Author(s): Yaqi Wang
- Abstract
Loading... -
+
P3.16-36 - Adjuvant Chemotherapy May Improve the Outcome of Patients with Non-Small-Cell Lung Cancer with Metastasis of Intrapulmonary Lymph Nodes.
12:00 - 13:30 | Author(s): Xing Wang
- Abstract
Loading... -
+
P3.16-37 - Comparison of Long-Term Outcomes Between VATS and Open Lobectomies for Stage I NSCLC: Propensity Score-Matching Analysis
12:00 - 13:30 | Presenter: Risa Oda
- Abstract
Loading... -
+
P3.16-38 - Systematic Review and Meta-Analysis of Methods to Predict Postoperative Lung Function Following Lung Cancer Resection
12:00 - 13:30 | Presenter: Nicola Oswald
- Abstract
Loading... -
+
P3.16-39 - Which Surgery for Ground Glass Opacity Lung Nodules?
12:00 - 13:30 | Presenter: Sara Ricciardi
- Abstract
Loading... -
+
P3.16-40 - Delayed Cut-End Recurrence After Wedge Resection for Pulmonary Ground-Glass Opacity Adenocarcinoma
12:00 - 13:30 | Presenter: Keigo Sekihara
- Abstract
Loading... -
+
P3.16-41 - Postoperative Pembrolizumab for the Patients with Pathologic Stage I Adenocarcinoma with Solid or Micropapillary Pattern
12:00 - 13:30 | Presenter: Sumin Shin
- Abstract
Loading... -
+
P3.16-42 - Early Stage Non-Small Cell Lung Cancer Survival in a Chilean Private Teaching Hospital
12:00 - 13:30 | Presenter: Francisco Suárez
- Abstract
Loading... -
+
P3.16-43 - Is Sublobar Resection for Stage I Invasive Adenocarcinoma (≤2-cm) Feasible?
12:00 - 13:30 | Presenter: Yuriko Terada
- Abstract
Loading... -
+
P3.16-44 - Robotic-Assisted Thoracic Surgery for Early-Stage Non-Small-Cell Lung Cancer: Initial Experience in Brazil
12:00 - 13:30 | Presenter: Ricardo Mingarini Terra
- Abstract
Loading... -
+
P3.16-45 - The Rates and Survival of Surgically-Resected Second Primary Lung Cancers in Patients Undergoing Resection of an Initial Primary Lung Cancer.
12:00 - 13:30 | Presenter: John Michael Varlotto
- Abstract
Loading... -
+
P3.16-46 - The Comparison Between Non-Intubated and Intubated Thoracoscopic Resection for Pulmonary Nodule: A Meta-Analysis
12:00 - 13:30 | Presenter: Yaokai Wen
- Abstract
Loading... -
+
P3.16-47 - Analysis of The Novel Chest Tube (Coaxial Drain) for Lung Cancer Surgery
12:00 - 13:30 | Presenter: Masashi Yanada
- Abstract
Loading... -
+
P3.16-48 - Is Preoperative SUV(Max) of Primary Tumor a Predictor of Relapse for Operable Non-Small Cell Lung Cancer?
12:00 - 13:30 | Author(s): Ozkan Alan
- Abstract
Loading...
-
+
P3.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 23
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.17-01 - PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients from Brazil
12:00 - 13:30 | Author(s): Antonio Vinicius Alves Da Silva
- Abstract
Loading... -
+
P3.17-02 - Increasing Radiation Dose to Central Structures is Associated with Worse Survival Following Thoracic Proton Reirradiation
12:00 - 13:30 | Presenter: Jessika Anny Contreras
- Abstract
Loading... -
+
P3.17-03 - Survival and Side Effects in Non-Small Cell Lung Cancer Patients Treated with Combination of Chemotherapy and Conformal Radiotherapy
12:00 - 13:30 | Presenter: Simonida Crvenkova
- Abstract
Loading... -
+
P3.17-04 - Dealing with the N2 Disesase in Non- Small Cell Lung Cancer- on the Edge.
12:00 - 13:30 | Presenter: Soo-Youn Ham
- Abstract
Loading... -
+
P3.17-05 - Multimodality Treatment for Superior Sulcus Non-Small-Cell Lung Carcinomas
12:00 - 13:30 | Presenter: Masahiko Harada
- Abstract
Loading... -
+
P3.17-06 - Impact of Integrating PET-CT in Radiotherapy Planning of Non Small Cell Carcinoma Lung: Dosimetric and Radiobiological Comparison
12:00 - 13:30 | Presenter: Rakesh Kapoor
- Abstract
Loading... -
+
P3.17-07 - The Beneficial Effect of the High Dose Irradiation During Concurrent Chemoradiotherapy in Locoregional Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Chul Seung Kay
- Abstract
Loading... -
+
P3.17-08 - Assessing Primary Lung Cancer Lesion Using Ratio Metrics of T1 and T2-Weighted Images in Magnetic Resonance Imaging
12:00 - 13:30 | Author(s): Bo Qiu
- Abstract
Loading... -
+
P3.17-09 - Retrospective Analysis of the Efficacy and Safety of Multimodal Treatment for Locally-Advanced NSCLC in Elderly Patients
12:00 - 13:30 | Presenter: Francesca Mazzoni
- Abstract
Loading... -
+
P3.17-10 - Outcome of Surgical Resection for Superior Sulcus Tumor: Experience at a Single Institution.
12:00 - 13:30 | Presenter: Seiji Omura
- Abstract
Loading... -
+
P3.17-11 - Duo Synchronous Primary Lung Tumours Mimicking a Solitary Spiculated Cavitatory Mass on Computed Tomographic Imaging
12:00 - 13:30 | Presenter: Kingsfield Ong
- Abstract
Loading... -
+
P3.17-12 - Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress
12:00 - 13:30 | Presenter: Helen J Ross
- Abstract
Loading... -
+
P3.17-13 - SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients with Stage IIIA(N2) NSCLC — A Multicenter Single-Arm Phase II Trial.
12:00 - 13:30 | Presenter: Sacha I Rothschild
- Abstract
Loading... -
+
P3.17-14 - A Case of a Patient Harboring an EGFR -T790M Mutation Positive in Squamous Cell Lung Cancer
12:00 - 13:30 | Author(s): Thanya Runciman
- Abstract
Loading... -
+
P3.17-15 - Therapeutic Outcome of Surgery for Superior Sulcus Tumor
12:00 - 13:30 | Presenter: Akira Sakurada
- Abstract
Loading... -
+
P3.17-16 - Adenocarcinoma or Epidermoid? The Importance of the Histological Subdivision
12:00 - 13:30 | Presenter: Silvia Sequero
- Abstract
Loading... -
+
P3.17-17 - Stage III: Analysis to Assist in the Decision of Surgery Against Quimio-Radiotherapy
12:00 - 13:30 | Presenter: Silvia Sequero
- Abstract
Loading... -
+
P3.17-18 - Towards Individualizing Patient Selection in Proton Therapy for Lung Cancer Using the Model-Based Approach
12:00 - 13:30 | Presenter: Suliana Teoh
- Abstract
Loading... -
+
P3.17-19 - First Relapse and Survival Five Years After Radical Radiotherapy for Lung Cancer.
12:00 - 13:30 | Presenter: Gerard Walls
- Abstract
Loading... -
+
P3.17-20 - Impact of Significant Primary Tumor Size Reduction on Radiation Dose to Normal Structures in Patients Receiving Definitive Chemoradiotherapy
12:00 - 13:30 | Presenter: Meng Xu Welliver
- Abstract
Loading... -
+
P3.17-21 - Surgical Treatment for Centrally Located or Hilar Invasive Locally Advanced Lung Cancer.
12:00 - 13:30 | Presenter: Motohiro Yamashita
- Abstract
Loading... -
+
P3.17-22 - Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable NSCLC
12:00 - 13:30 | Presenter: Ralph Goldman Zinner
- Abstract
Loading... -
+
P3.17-23 - Role of Surgery in Locoregional Advanced NSCLC; A Case of Aggressive Salvage Surgery After Definitive Chemoradiation
12:00 - 13:30 | Presenter: Ryuichi Waseda
- Abstract
Loading...
-
+
P3.CR - Case Reports (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 36
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.CR-01 - To Better Understand the Anatomical Proximity of Cardiac Plexus to Prevent Lethal Arrhythmias Associated with Lung Cancer Surgery
12:00 - 13:30 | Presenter: Kurumi Fukui
- Abstract
Loading... -
+
P3.CR-02 - SBRT of Lung Primary After Complete Resolution of Metastatic Disease in Case of EGFR Mutated Adenocarcinoma Lung: A Case Report
12:00 - 13:30 | Presenter: Saroj Kumar Das Majumdar
- Abstract
Loading... -
+
P3.CR-03 - Pulmonary Spindle Cell Neoplasm - Neoadjuvant Treatment and Response
12:00 - 13:30 | Author(s): Amr Ismail
- Abstract
Loading... -
+
P3.CR-04 - Lung Cancer with Concurrent ROS1 Rearrangement and KRAS Mutation: A Case Report
12:00 - 13:30 | Presenter: Youcai Zhu
- Abstract
Loading... -
+
P3.CR-05 - The Role of Patient Engagement in Improved Outcomes in Lung Cancer Care
12:00 - 13:30 | Presenter: Anne Marie Cerato
- Abstract
Loading... -
+
P3.CR-06 - Effect of Palliative Care and Cancer Rehabilitation on Lung Cancer Survivorship - Patient's Perspective
12:00 - 13:30 | Presenter: Satoko Kono
- Abstract
Loading... -
+
P3.CR-07 - Comprehensive Genomic Profiles for a Mediastinal Tumor Suspected of Synovial Sarcoma: A Case Report
12:00 - 13:30 | Presenter: Kota Araki
- Abstract
Loading... -
+
P3.CR-08 - Clonally Related Primary ALK Rearrangement Adenocarcinoma and Associated Metastatic Lesions: A Case Report
12:00 - 13:30 | Author(s): Wenxian Wang
- Abstract
Loading... -
+
P3.CR-09 - MET-UBE2H fusion as a novel mechanism of acquired EGFR resistance in
lung adenocarcinoma" with "MET fusion as a novel mechanism of acquired EGFR resistance in
lung adenocarcinoma12:00 - 13:30 | Author(s): Wenxian Wang
- Abstract
Loading... -
+
P3.CR-10 - HIP1-ALK Fusion Variant in Non-Small-Cell Lung Cancer and Response to Crizotinib
12:00 - 13:30 | Author(s): Wenxian Wang
- Abstract
Loading... -
+
P3.CR-11 - ROS1 Fusion and MET Amplification Dual Drive Coexistence in Lung Adenocarcinoma and Response to Crizotinib: A Case Report
12:00 - 13:30 | Presenter: Chunwei Xu
- Abstract
Loading... -
+
P3.CR-12 - A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib
12:00 - 13:30 | Presenter: Chunwei Xu
- Abstract
Loading... -
+
P3.CR-13 - Dual Drive Coexistence of EML4-ALK Fusion and TPM3-ROS1 Fusion Lung Adenocarcinoma: A Case Report
12:00 - 13:30 | Presenter: Youcai Zhu
- Abstract
Loading... -
+
P3.CR-14 - A Case of EGFR Tyrosine Kinase Inhibitor (TKI), Osimertinib Induced Pneumonitis in a Patient with Recurrent Fevers of Unknown Origin
12:00 - 13:30 | Author(s): Danielle Cuthbert
- Abstract
Loading... -
+
P3.CR-15 - Squamous Cell Carcinoma Diagnosed While on Immunotherapy for Lung Adenocarcinoma: A Unique Clinical Case.
12:00 - 13:30 | Author(s): Sara Coelho
- Abstract
Loading... -
+
P3.CR-16 - A Case of Toxic Hepatic Event Occurring in Combination Treatment with Nivolumab and Anti-Tuberculosis in Advanced Lung Cancer
12:00 - 13:30 | Presenter: Tae Hoon Kim
- Abstract
Loading... -
+
P3.CR-17 - An Interesting Case of Long-Term Immunotherapy Response in Metastatic NSCLC
12:00 - 13:30 | Presenter: Swati Kulkarni
- Abstract
Loading... -
+
P3.CR-18 - Central Nervous System Activity of Checkpoint Inihibitor in Non-Small-Cell Lung Cancer
12:00 - 13:30 | Presenter: Marta Nassif Pereira-Lima
- Abstract
Loading... -
+
P3.CR-19 - Thromboembolic Events Related to Immunotherapy in a NSCLC Patient: A Case Report.
12:00 - 13:30 | Author(s): Jessica Tsukamoto
- Abstract
Loading... -
+
P3.CR-20 - The Effect of Pembrolizumab In EGFR Mutated Lung Adenocarcinoma Patients With PD-L1 Overexpression: Two Cases Report
12:00 - 13:30 | Presenter: Takeshi Uenami
- Abstract
Loading... -
+
P3.CR-21 - Utility of Thoracoscopy in Diagnosis of Lung Tumour in Pleural Effusion
12:00 - 13:30 | Presenter: Naveen Pandhi
- Abstract
Loading... -
+
P3.CR-22 - Pulmonary Tuberculosis – A Chameleon; Mimicking Lung Cancer on Imaging
12:00 - 13:30 | Author(s): Naveen Pandhi
- Abstract
Loading... -
+
P3.CR-23 - Multilobar Adenocarcinoma: A Case Report and Review of the Literature of Papillary Eccrine Adenocarcinoma Presenting with Respiratory Failure.
12:00 - 13:30 | Presenter: J. Francis Turner
- Abstract
Loading... -
+
P3.CR-24 - Surgical Resection of 30 Years’ Recurring Pneumonia: 1 Case of Giant Bronchopulmonary Sequestration
12:00 - 13:30 | Presenter: Jun Zhang
- Abstract
Loading... -
+
P3.CR-25 - Finding the Ways to Determine the Prognosis of Pulmonary Carcinoids with Certain Genes/Markers in Pakistan
12:00 - 13:30 | Presenter: Arooj Fatima
- Abstract
Loading... -
+
P3.CR-26 - Mediastinal Lipoma in Adult: A Case Report
12:00 - 13:30 | Presenter: Amira Binti Anwar
- Abstract
Loading... -
+
P3.CR-27 - Surgical Treatment of a Rare Case of Mediastinal Masson's Tumor Mimicking a Thymoma
12:00 - 13:30 | Presenter: Angela De Palma
- Abstract
Loading... -
+
P3.CR-28 - Simultaneous Presentation of Mediastinal Malignant Peripheral Nerve Sheath Tumor with Intrapulmonary Metastasis, an Extremely Rare Case
12:00 - 13:30 | Author(s): H.Volkan Kara
- Abstract
Loading... -
+
P3.CR-29 - En-Bloc Excision of Intrapericardial Thymoma Using Single Port Video-Assisted Thoracoscopic Surgery. A Rare Case
12:00 - 13:30 | Author(s): H.Volkan Kara
- Abstract
Loading... -
+
P3.CR-30 - Pleural Diseases on Single Lung After Pneumonectomy for Cancer
12:00 - 13:30 | Author(s): Natalia Motas
- Abstract
Loading... -
+
P3.CR-31 - A Case of Thymoma with Autoimmune Hepatitis Following Preoperative Chemotherapy
12:00 - 13:30 | Presenter: Tomoki Nishimura
- Abstract
Loading... -
+
P3.CR-32 - Amyloid Deposition in Thymic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue: A Case Report
12:00 - 13:30 | Presenter: Kyung Joo Park
- Abstract
Loading... -
+
P3.CR-33 - Trichoptysis, Hemoptysis and Chest Pain: A Very Rare Presentation of Anterior Mediastinal Teratoma in a Young Patient
12:00 - 13:30 | Presenter: Asma Saidane
- Abstract
Loading... -
+
P3.CR-34 - A Giant Ganglioneuroma of the Thoracic Spine
12:00 - 13:30 | Presenter: Asma Saidane
- Abstract
Loading... -
+
P3.CR-35 - A Rare Giant Thoracic Desmoid Tumor /A Case Report
12:00 - 13:30 | Presenter: Asma Saidane
- Abstract
Loading... -
+
P3.CR-37 - Extensive Resection for Invasive Atypical Carcinoid of Thymus: 1 Case Report
12:00 - 13:30 | Presenter: Jun Zhang
- Abstract
Loading...
-
+
ES07 - Beyond the Diagnosis - Collaborative Care for Change
- Type: Educational Session
- Track: Nursing and Allied Professionals
- Presentations: 6
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 205 BD
-
+
ES07.01 - A Moment in Time for the Unplanned Conversations
13:30 - 13:50 | Presenter: Kelly McGuigan
- Abstract
No abstract available for this presentation
-
+
ES07.02 - Special Needs and Wellness in Lung Cancer Patients - Australian Perspective
13:50 - 14:00 | Presenter: Maria Ftanou
- Abstract
No abstract available for this presentation
-
+
ES07.03 - Special Needs and Wellness in Lung Cancer Patients - European Perspective
14:00 - 14:10 | Presenter: Rossie Navon
- Abstract
No abstract available for this presentation
-
+
ES07.04 - Leveraging Social Media to Change the Public Conversation on Lung Cancer Stigma
14:10 - 14:30 | Presenter: Lisa Carter-Harris
- Abstract
No abstract available for this presentation
-
+
ES07.05 - Research Update: Patient’s Perspective on Living with Malignant Pleural Mesothelioma
14:30 - 14:50 | Presenter: Angela Mary Tod
- Abstract
No abstract available for this presentation
-
+
ES07.06 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES08 - The Pathologist - An Essential Member of the Patient Care Team
- Type: Educational Session
- Track: Pathology
- Presentations: 5
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 206 AC
-
+
ES08.01 - Targeted Therapy
13:30 - 13:50 | Presenter: Yasushi Yatabe
- Abstract
No abstract available for this presentation
-
+
ES08.02 - Immunotherapy
13:50 - 14:10 | Presenter: Sylvie Lantuejoul
- Abstract
No abstract available for this presentation
-
+
ES08.03 - Mesothelioma, Thymic Epithelial Tumors and Others
14:10 - 14:30 | Presenter: Andrew G Nicholson
- Abstract
No abstract available for this presentation
-
+
ES08.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES08.04 - Neoadjuvant Therapy
14:30 - 14:50 | Presenter: Ignacio I. Wistuba
- Abstract
No abstract available for this presentation
-
+
LA01 - IASLC Lectureship Award Session
- Type: Lectureship Award Session
- Track:
- Presentations: 9
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 105
-
+
LA01.01 - Clifton F. Mountain Lectureship Award for Staging - Is There Still a Stage for Improvements in Staging?
13:30 - 13:40 | Presenter: Johan F. Vansteenkiste
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
LA01.02 - IASLC Lectureship Award for Radiation Oncology - Defining the Role of Radiotherapy for Lung Cancer: Past, Present and Future
13:40 - 13:50 | Presenter: Hak Choy
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
LA01.03 - Heine H. Hansen Lectureship Award for Small Cell Lung Cancer - New Opportunities in Small Cell Lung Cancer
13:50 - 14:00 | Presenter: Charles M. Rudin
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
LA01.04 - Adi F. Gazdar Lectureship Award for Translational Research - Genomic Alterations in Human Lung Cancers
14:00 - 14:10 | Presenter: Matthew Meyerson
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
LA01.05 - Tsuguo Naruke Lectureship Award for Surgery - The Value of Naruke Lymph Node Chart and the Creation of IASLC Chart in Lung Cancer
14:10 - 14:20 | Presenter: Hisao Asamura
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
LA01.06 - Daniel C. Ihde Lectureship Award for Medical Oncology - The Intersection of Science and Medicine
14:20 - 14:30 | Presenter: David P Carbone
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
LA01.07 - Robert J. Ginsberg Lectureship Award for Surgery - Honoring the Tradition of Surgically-Based Clinical Trials
14:30 - 14:40 | Presenter: Valerie W Rusch
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
LA01.08 - IASLC Lectureship Award for Nursing and Allied Health Professionals - The Right Hand: The Art of Collaboration
14:40 - 14:50 | Presenter: Kimberly Ann Rohan
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
LA01.09 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
MA25 - Oligometastasis: Defining, Treating, and Evaluating
- Type: Mini Oral Abstract Session
- Track: Oligometastatic NSCLC
- Presentations: 12
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 203 BD
-
+
MA25.01 - EORTC Lung Cancer Group Survey to Define Synchronous Oligometastatic Disease in NSCLC
13:30 - 13:35 | Author(s): Antonin Levy
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.03 - Defining Oligometastatic Non-Small Cell Lung Cancer (NSCLC): An Evolving Multidisciplinary Expert Opinion
13:35 - 13:40 | Presenter: Lizza Hendriks
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.02 - Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts
13:40 - 13:45 | Presenter: Anne-Marie C. Dingemans
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.04 - Discussant - MA 25.01, MA 25.02, MA 25.03
13:45 - 14:00 | Presenter: Abraham J. Wu
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.05 - Characteristics & Survival of Resected Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Mid-South Quality of Surgical Resection Cohort
14:00 - 14:05 | Presenter: Nicholas R. Faris
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.06 - RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit from Local Consolidative Treatment
14:05 - 14:10 | Presenter: Jia-Tao Zhang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.07 - Effectiveness of Systemic Therapy Combined with Thoracic Radiotherapy for Patients with Oligometastatic NSCLC: A Pooled Analysis
14:10 - 14:15 | Author(s): Jingbo Wang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.08 - Discussant - MA 25.05, MA 25.06, MA 25.07
14:15 - 14:30 | Presenter: Alysa Fairchild
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.09 - M1b Disease in the 8th Edition of IASLC Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcom
14:30 - 14:35 | Presenter: Hyesun Park
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.10 - Complete Response by PET-CT After Radical Treatment in Oligometastatic Non-Small Cell Lung Cancer Predicts Longer Survival
14:35 - 14:40 | Author(s): Luis Antonio Cabrera-Miranda
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.11 - Clinical and Molecular Predictors of Outcome in Patients with EGFR mutant NSCLC Brain Metastases treated with RT
14:40 - 14:45 | Presenter: Fabio Y Moraes
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA25.12 - Discussant - MA 25.09, MA 25.10, MA 25.11
14:45 - 15:00 | Presenter: Michael Macmanus
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 12
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 201 BD
-
+
MA26.01 - Accumulation of Concomitant Mutations Involved in Drug Resistance in the Sequential ALK TKI Treatments of ALK-Positive NSCLC
13:30 - 13:35 | Presenter: Shun Lu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.02 - Upfront or Sequential Strategy for New Generation Anaplastic Lymphoma Kinase (ALK) Inhibitors: An Italian Retrospective Study.
13:35 - 13:40 | Presenter: Elisa Gobbini
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.03 - Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient with Acquired RET Rearrangement
13:40 - 13:45 | Presenter: Zofia Piotrowska
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.04 - Discussant - MA 26.01, MA 26.02, MA 26.03
13:45 - 14:00 | Presenter: Caroline McCoach
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.05 - Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients with Different ALK Fusion-Variants
14:00 - 14:05 | Presenter: Meng Qiao
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.06 - Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative
14:05 - 14:10 | Presenter: Erik Thunnissen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.07 - ROS1 (SP384) Immunohistochemistry Inter-Reader Precision Between 12 Pathologists
14:10 - 14:15 | Author(s): Amy Elizabeth Hanlon Newell
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.08 - Discussant - MA 26.05, MA 26.06, MA 26.07
14:15 - 14:30 | Presenter: Dong-Wan Kim
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.09 - Lazertinib, a Third Generation EGFR-TKI, in Patients with EGFR-TKI-Resistant NSCLC: Updated Results of a Phase I/II Study
14:30 - 14:35 | Presenter: Byoung Chul Cho
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.10 - CNS Activity of Ramucirumab in Combination with Osimertinib in Patients with Advanced T790M-Positive EGFR-Mutant NSCLC
14:35 - 14:40 | Presenter: Luis Paz-Ares
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.11 - Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC
14:40 - 14:45 | Author(s): Tony S. Mok
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA26.12 - Discussant - MA 26.09, MA 26.10, MA 26.11
14:45 - 15:00 | Presenter: Liza Villaruz
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
first
prev
